ISA Pharmaceuticals B.V.
Records under this name other than the patents ISA Pharmaceuticals B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 5 of 5 · Back to ISA Pharmaceuticals B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,314,521 | Adjuvant compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,770,506 | Adjuvant compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,458,198 | HPV Epitopes Targeted by T Cells Infiltrating Cervical Malignancies for Use in Vaccines Lapsed on the fee record Ended Oct 4, 2026 · High confidence | Lapsed on the fee record | Ended Oct 4, 2026 | High confidence |
| US 9,764,023 | HPV Epitopes Targeted by T Cells Infiltrating Cervical Malignancies for Use in Vaccines Lapsed on the fee record Ended Sep 19, 2025 · High confidence | Lapsed on the fee record | Ended Sep 19, 2025 | High confidence |
| US 10,688,173 | HPV Epitopes Targeted by T Cells Infiltrating Cervical Malignancies for Use in Vaccines Lapsed on the fee record Ended Jun 23, 2024 · High confidence | Lapsed on the fee record | Ended Jun 23, 2024 | High confidence |